ArticleCanadian journal of gastroenterology & hepatology2026
Caesalpinia Sappan Wood Extract Alleviates Ferroptosis-Like Oxidative Injury and Restores Macrophage Polarization Balance in Iron Overload-Induced Liver Fibrosis in Rats.
Article in Canadian journal of gastroenterology & hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Caesalpinia Sappan Wood Extract Alleviates Ferroptosis-Like Oxidative Injury and Restores Macrophage Polarization Balance in Iron Overload-Induced Liver Fibrosis in Rats.Canadian journal of gastroenterology & hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Iron overload-induced liver fibrosis involves interconnected pathological drivers: ferroptosis-like oxidative injury and dysregulated macrophage polarization. Although Caesalpinia sappan L. possesses well-characterized antioxidant and anti-inflammatory properties, its efficacy against this dual pathological axis has not been experimentally established. This study investigated the hepatoprotective effects of C. sappan wood extract (SWE) in an iron dextran-induced rat model of liver fibrosis. Male Wistar rats received intraperitoneal iron dextran (cumulative dose of 180 mg/kg BW over 39 days) to induce hepatic iron overload, followed by 28-day oral administration of SWE (25, 50, 75, or 100 mg/kg BW/day) or deferasirox (20 mg/kg BW/day). Hepatic iron concentration, liver function markers, oxidative stress parameters (MDA, SOD, and GPx4), macrophage polarization markers (CD86 and CD163), inflammatory and fibrogenic mediators (IL-6, IL-10, TGF-β1, and MMP-12), and fibrosis severity were assessed through biochemical, immunohistochemical, and histopathological analyses. SWE was standardized to 25.12% w/w brazilin by HPLC-PDA. SWE showed dose-related effects with optimal efficacy at intermediate doses, reducing hepatic iron burden, restoring GPx4 activity, suppressing lipid peroxidation, and enhancing antioxidant defense, collectively attenuating ferroptosis-like oxidative injury. Concurrently, SWE reduced M1 macrophage activation (decreased CD86 and IL-6) while promoting M2 polarization (increased CD163 and IL-10), suppressed TGF-β1-driven fibrogenesis, and restored MMP-12-mediated matrix remodeling, resulting in significant reductions in collagen deposition and fibrotic area. SWE performed comparably to deferasirox across most endpoints, with superior MMP-12 recovery. SWE simultaneously attenuates ferroptosis-like oxidative injury and restores macrophage polarization balance, establishing it as a mechanistically coherent multitarget candidate for iron overload-induced liver fibrosis with translational potential beyond that of iron chelation alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.